ADVERTISEMENT

Stock Market LIVE: Nifty Slips Below 24,800, Sensex Slumps Over 200 Points As ICICI Bank & HDFC Bank Drag

Pharma and defence stocks were biggest laggard on the National Stock Exchange.

<div class="paragraphs"><p>The NSE Nifty 50 and BSE Sensex fell significantly as tension increased before the US tariff deadline on Aug 27. (Photo: Freepik)</p></div>
The NSE Nifty 50 and BSE Sensex fell significantly as tension increased before the US tariff deadline on Aug 27. (Photo: Freepik)
ADVERTISEMENT
Good morning! Welcome to NDTV Profit's blog for real-time market coverage. The NSE Nifty 50 and BSE Sensex erased all gains from previous session as ICICI Bank Ltd. and Bharti Airtel Ltd. shares declined. The Nifty 50 may find support at 24,800.
LIVE FEED
Latest First
  • Oldest First

Stock Market LIVE: HDFC Bank Share Price Falls After Turning Ex-Date

HDFC Bank Ltd. share price declined after the stock turned ex-bonus. With Tuesday's losses, the stock price has fallen three session in a row.

The private lender has given one free bonus equity share of face value of Rs 1 each for every one fully paid-up equity share held.

Stock Market LIVE: Nifty Slips Below 24,800, Sensex Slumps Over 200 Points As ICICI Bank & HDFC Bank Drag

Sectoral Performance At Open: Nifty Pharma Underperforms

On National Stock Exchange, 14 sectoral indices opened lower with the NSE Nifty Pharma declining the most. The NSE Nifty FMCG rose the most.

Stock Market LIVE: Nifty Slips Below 24,800, Sensex Slumps Over 200 Points As ICICI Bank & HDFC Bank Drag

Nifty Detractors: ICICI Bank, HDFC Bank And Sun Pharma Weigh

ICICI Bank Ltd., HDFC Bank Ltd., Sun Pharmaceutical Industries Ltd., Bharti Airtel Ltd., and Reliance Industries Ltd. weighed on the NSE Nifty 50 index.

Hindustan Unilever Ltd., Titan Co. Ltd., Eicher Motors Ltd., Nestle India Ltd., and Hero MotoCorp Ltd. limited losses in the NSE Nifty 50 index.

Stock Market LIVE: Nifty Slips Below 24,800, Sensex Slumps Over 200 Points As ICICI Bank & HDFC Bank Drag

India Most Expensive Among Emerging Markets, High Valuations Valid: HSBC

India is expensive for valid reasons— high return on equity, higher long-term growth potential and domestic appetite for equities, noted HSBC in its latest India Strategy note released on Tuesday.

The brokerage believes that the perceived risk for India is lower due to strong and proactive regulatory framework and institutions. Near-term slow growth and long-term deterioration in ROEs are downside risks, as per HSBC.

Opinion
India Most Expensive Among Emerging Markets, High Valuations Valid: HSBC

Reliance Industries Gets A Target Price Hike From UBS Ahead Of AGM

International investment firm UBS resumed coverage on Reliance Industries Ltd. with a 'buy' rating and hiked the 12-month target price of the stock. This comes ahead of the RIL annual general meeting on Friday, Aug. 29.

Analysts expect RIL to perform well in the coming 12 to 18 months as the group's earnings transformation of last five years open path towards value unlocking.

Opinion
Reliance Industries Gets A Target Price Hike From UBS Ahead Of AGM; Jio IPO Likely Next Year













OUR NEWSLETTERS
By signing up you agree to the Terms & Conditions of NDTV Profit